专利检索 ap:("BAYER PHARMA AKTIENGESELLSCHAFT") AND inv:"Markus BERGER" 第 1 页

1.

发明公开
N-[2-({4-[3-(ANILINO)-4-OXO-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-2-YL]PYRIDIN-3-YL)OXY)ETHYL]PROP-2-ENAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER 审中-公开

公开(公告)号：US20230416249A1

公开(公告)日：2023-12-28

申请号：US18315472

申请日：2023-05-10

申请人： Bayer Aktiengesellschaft , Bayer Pharma Aktiengesellschaft , The Broad Institute, Inc. , Dana-Farber Cancer Institute, Inc.

发明人： Stephan SIEGEL , Franziska SIEGEL , Volker SCHULZE , Markus BERGER , Keith GRAHAM , Ulrich KLAR , Jeremie Xavier G. MORTIER , Detlev SÜLZLE , Ulf BÖMER , Daniel KORR , Jens SCHRÖDER , Matthew MEYERSON , Heidi GREULICH , Bethany KAPLAN

IPC分类号： C07D471/04 , A61P35/00 , G01N33/574

CPC分类号： C07D471/04 , A61P35/00 , G01N33/57492 , G01N2333/71

摘要： Compounds of formula (I)

processes for their production and their use as pharmaceuticals.

2.

发明申请
HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING 有权

公开(公告)号：US20210221798A1

公开(公告)日：2021-07-22

申请号：US17218907

申请日：2021-03-31

申请人： BAYER PHARMA AKTIENGESELLSCHAFT

发明人： Markus BERGER , Jessica LOHRKE , Christoph-Stephan HILGER , Gregor JOST , Thomas FRENZEL , Olaf PANKNIN , Hubertus PIETSCH

IPC分类号： C07D403/14 , A61K49/10 , C07D257/02

摘要： The present invention relates to a new class of high relaxivity extracellular gadolinium chelate complexes, to methods of preparing said compounds, and to the use of said compounds as MRI contrast agents.

3.

发明申请
HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING 审中-公开

公开(公告)号：US20200283420A1

公开(公告)日：2020-09-10

申请号：US16463076

申请日：2017-11-24

申请人： BAYER PHARMA AKTIENGESELLSCHAFT

发明人： Markus BERGER , Jessica LOHRKE , Christoph-Stephan HILGER , Gregor JOST , Thomas FRENZEL , Olaf PANKNIN , Hubertus PIETSCH

IPC分类号： C07D403/14 , A61K49/10 , C07D257/02

摘要： The present invention relates to a new class of high relaxivity extracellular gadolinium chelate complexes, to methods of preparing said compounds, and to the use of said compounds as MRI contrast agents.

4.

发明申请
FURANE DERIVATIVES AS INHIBITORS OF ATAD2 审中-公开

公开(公告)号：US20190218196A1

公开(公告)日：2019-07-18

申请号：US15779691

申请日：2016-11-30

申请人： BAYER PHARMA AKTIENGESELLSCHAFT

发明人： Markus BERGER , Jan HÜBNER , Antonius TER LAAK , Matyas GORJANACZ , Amaury Ernesto FERNANDEZ-MONTALVAN , Vincent RODESCHINI , Didier ROCHE

IPC分类号： C07D307/52 , C07D405/12 , C07D487/10 , A61K45/06 , A61K31/341 , A61K31/4025 , A61K31/5377 , A61K31/496 , A61K31/4178 , A61K31/4196 , A61K31/4525 , A61K31/397 , A61K31/403

CPC分类号： C07D307/52 , A61K31/341 , A61K31/397 , A61K31/4025 , A61K31/403 , A61K31/4178 , A61K31/4196 , A61K31/4525 , A61K31/496 , A61K31/5377 , A61K45/06 , C07D307/38 , C07D405/12 , C07D487/10

摘要： The invention relates to furane derivatives of formula (I) as inhibitors of ATAD2, a process for their preparation and use thereof.